News Feed

Latest News

AWAKN press release
Press Release

Professor David Nutt Joins AWAKN Life Sciences

Former UK Government Drug TSAR Appointed as Chairman of Scientific Advisory Board Toronto, Ontario–(Newsfile Corp. – July 7, 2020) – AWAKN Life Sciences Inc. (“AWAKN”)



Spencer Hawkswell TheraPsil

Spencer Hawkswell, TheraPsil

We spoke to Spencer Hawkswell, Executive Director of TheraPsil: a non-profit advocacy group seeking to facilitate legal access to psilocybin therapy for terminally-ill patients.


JR Rahn, MindMed

We spoke to JR Rahn, Co-Founder, Director & Co-CEO of MindMed. We asked JR about his Company’s clinical trials, how COVID-19 has affected their operations,

Stay in the loop

Join our Newsletter

Industry insights and interviews delivered to your inbox. No spam, just valuable information.